Literature DB >> 8238656

Treatment of clozapine sedation.

M Burke, C S Sebastian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8238656     DOI： 10.1176/ajp.150.12.1900

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  7 in total

1.  Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionality.

Authors:  Julie B Penzner; Melissa Dudas; Ema Saito; Vladimir Olshanskiy; Umesh H Parikh; Sandeep Kapoor; Raja Chekuri; Dominick Gadaleta; Jennifer Avedon; Eva M Sheridan; Jane Randell; Anil K Malhotra; John M Kane; Christoph U Correll
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-10       Impact factor: 2.576

2.  Management of common adverse effects of antipsychotic medications.

Authors:  T Scott Stroup; Neil Gray
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

3.  Different behavioral effects of haloperidol, clozapine and thioridazine in a concurrent lever pressing and feeding procedure.

Authors:  J D Salamone; M S Cousins; C Maio; M Champion; T Turski; J Kovach
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

4.  Systemic administration of the adenosine A(2A) agonist CGS 21680 induces sedation at doses that suppress lever pressing and food intake.

Authors:  Susana Mingote; Mariana Pereira; Andrew M Farrar; Peter J McLaughlin; John D Salamone
Journal:  Pharmacol Biochem Behav       Date:  2008-01-17       Impact factor: 3.533

5.  The receptor mechanisms underlying the disruptive effects of haloperidol and clozapine on rat maternal behavior: a double dissociation between dopamine D(2) and 5-HT(2A/2C) receptors.

Authors:  Changjiu Zhao; Ming Li
Journal:  Pharmacol Biochem Behav       Date:  2009-06-17       Impact factor: 3.533

6.  A review of modafinil and armodafinil as add-on therapy in antipsychotic-treated patients with schizophrenia.

Authors:  Laura Christina Wittkampf; Johannes Arends; Leo Timmerman; Marike Lancel
Journal:  Ther Adv Psychopharmacol       Date:  2012-06

7.  Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial.

Authors:  Oliver Freudenreich; David C Henderson; Eric A Macklin; A Eden Evins; Xiaoduo Fan; Cori Cather; Jared P Walsh; Donald C Goff
Journal:  J Clin Psychiatry       Date:  2009-08-11       Impact factor: 4.384
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.